Insider Trading Activity - ARCH Venture Partners VIII LLC

Real time insider trading transaction history:

Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Insider Trading Transactions for ARCH Venture Partners VIII LLC

Common stock purchase or sale:

Transaction Date	Reported DateTime	Company	Symbol	Insider Relationship	Shares Traded	Average Price	Total Amount	Shares Owned	Filing
2023-09-19 Purchase	2023-09-20 06:15 am	Neumora Therapeutics Inc.	NMRA	ARCH Venture Partners X LLC ARCH Venture Fund X L.P. ARCH Venture Partners X L.P. ARCH Venture Fund X Overage L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Partners VII LLC ARCH Venture Partners VII L.P. ARCH Venture Fund VII L.P. ARCH Venture Partners VIII LLC ARCH Venture Fund VIII Overage L.P. 10% Owner	1,500,000	$17	$25,500,000	3,624,143 (Indirect)	View
2022-09-13 Purchase	2022-09-15 6:53 pm	Codiak BioSciences Inc.	CDAK	ARCH Venture Fund VIII L.P. ARCH Venture Fund VIII Overage L.P. CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT ARCH Venture Partners VIII LLC ARCH Venture Partners VIII L.P. 10% Owner	5,000,000	$1.5	$7,500,000	13,854,098 (Indirect Direct)	View
2020-10-16 Purchase	2020-10-20 8:07 pm	Codiak BioSciences Inc.	CDAK	ARCH Venture Fund VIII L.P. ARCH Venture Fund VIII Overage L.P. CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT ARCH Venture Partners VIII LLC ARCH Venture Partners VIII L.P. 10% Owner	235,000	$15	$3,525,000	2,503,903 (Indirect)	View
2020-09-18 Purchase	2020-09-22 11:07 am	Metacrine Inc.	MTCR	ARCH Venture Fund VIII L.P. ARCH Venture Fund VIII Overage L.P. CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT ARCH Venture Partners VIII LLC ARCH Venture Partners VIII L.P. 10% Owner	230,000	$13	$2,990,000	158,734 (Indirect)	View

Stock options: Exercise, Award, Grant, Conversion

Transaction Date	Reported DateTime	Exercisable Expiration	Company	Symnbol	Insider Relationship	Shares Traded	Conversion Price	Shares Owned	Filing
2023-12-08 Other	2023-12-12 7:52 pm	N/A N/A	Neumora Therapeutics Inc.	NMRA	ARCH Venture Partners X LLC ARCH Venture Fund X L.P. ARCH Venture Partners X L.P. ARCH Venture Fund X Overage L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Partners VII LLC ARCH Venture Partners VII L.P. ARCH Venture Fund VII L.P. ARCH Venture Partners VIII LLC ARCH Venture Fund VIII Overage L.P. 10% Owner	1,879,654	$0	32,424,564 (Indirect)	View
2023-09-19 Conversion	2023-09-20 06:15 am	N/A N/A	Neumora Therapeutics Inc.	NMRA	ARCH Venture Partners X LLC ARCH Venture Fund X L.P. ARCH Venture Partners X L.P. ARCH Venture Fund X Overage L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Partners VII LLC ARCH Venture Partners VII L.P. ARCH Venture Fund VII L.P. ARCH Venture Partners VIII LLC ARCH Venture Fund VIII Overage L.P. 10% Owner	17,424,704	$0	3,624,143 (Indirect)	View
Ownership	2023-09-14 9:22 pm	N/A N/A	Neumora Therapeutics Inc.	NMRA	ARCH Venture Partners X LLC ARCH Venture Fund X L.P. ARCH Venture Partners X L.P. ARCH Venture Fund X Overage L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Partners VII LLC ARCH Venture Partners VII L.P. ARCH Venture Fund VII L.P. ARCH Venture Partners VIII LLC ARCH Venture Fund VIII Overage L.P. 10% Owner	0	$0	28,045,420 (Indirect)	View
2020-11-20 Other	2020-11-24 8:59 pm	N/A N/A	Quanterix Corp	QTRX	ARCH VENTURE FUND VI LP ARCH Venture Fund VIII Overage L.P. ARCH VENTURE PARTNERS VI LP ARCH VENTURE PARTNERS VI LLC ARCH Venture Partners VIII LLC BYBEE CLINTON NELSEN ROBERT 10% Owner	833,211	$0	2,049,870 (Indirect)	View
2020-10-16 Conversion	2020-10-20 8:07 pm	N/A N/A	Codiak BioSciences Inc.	CDAK	ARCH Venture Fund VIII L.P. ARCH Venture Fund VIII Overage L.P. CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT ARCH Venture Partners VIII LLC ARCH Venture Partners VIII L.P. 10% Owner	30,658,565	$0	2,503,903 (Indirect)	View
Ownership	2020-10-13 9:23 pm	N/A N/A	Codiak BioSciences Inc.	CDAK	ARCH Venture Fund VIII L.P. ARCH Venture Fund VIII Overage L.P. CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT ARCH Venture Partners VIII LLC ARCH Venture Partners VIII L.P. 10% Owner	0	$0	3,620,109 (Indirect)	View
2020-09-18 Conversion	2020-09-22 11:07 am	N/A N/A	Metacrine Inc.	MTCR	ARCH Venture Fund VIII L.P. ARCH Venture Fund VIII Overage L.P. CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT ARCH Venture Partners VIII LLC ARCH Venture Partners VIII L.P. 10% Owner	2,710,503	$0	158,734 (Indirect)	View
Ownership	2020-09-15 5:07 pm	N/A N/A	Metacrine Inc.	MTCR	ARCH Venture Fund VIII L.P. ARCH Venture Fund VIII Overage L.P. CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT ARCH Venture Partners VIII LLC ARCH Venture Partners VIII L.P. 10% Owner	0	$0	2,710,503 (Indirect)	View
2019-08-08 Other	2019-08-12 8:47 pm	N/A N/A	Denali Therapeutics Inc.	DNI	ARCH Venture Fund VIII L.P. ARCH Venture Partners VIII L.P. ARCH Venture Partners VIII LLC BYBEE CLINTON CRANDELL KEITH 10% Owner	400,000	$0	11,068,749 (Direct)	View
2019-05-21 Other	2019-05-23 5:58 pm	N/A N/A	Homology Medicines Inc.	FIXX	ARCH Venture Fund VIII L.P. ARCH Venture Fund VIII Overage L.P. ARCH Venture Partners VIII L.P. ARCH Venture Partners VIII LLC BYBEE CLINTON CRANDELL KEITH NELSEN ROBERT 10% Owner	300,001	$0	6,068,695 (Direct)	View

Insider Trading & Ownership - ARCH Venture Partners VIII LLC